STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
STRATEC Biomedical AG
08.10.2014 14:27
Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
1. Threadneedle Asset Management UK Limited
Threadneedle Asset Management UK Limited, London, UK, has notified us
pursuant to sec. 21 para. 1 WpHG on 6 October 2014, that on 18 April 2013
the share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany,
ISIN: DE0007289001 went above the threshold of 5% and that the percentage
of voting rights on that day amounted to 5.35% (628,462 voting rights).
Threadneedle Asset Management UK Limited has notified us that these voting
rights of 5.35% (628,462 voting rights) are attributable to Threadneedle
Asset Management UK Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in
connection with sent. 2 WpHG.
The voting rights were attributed to Threadneedle Asset Management UK
Limited inter alia from Threadneedle Investment Funds ICVC, being a
shareholder holding 3% or more of the voting rights in STRATEC Biomedical
AG.
2. TAM UK Holdings Limited
TAM UK Holdings Limited, London, UK, has notified us pursuant to sec. 21
para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of voting
rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN: DE0007289001
went above the threshold of 5% and that the percentage of voting rights on
that day amounted to 5.35% (628,462 voting rights). TAM UK Holdings Limited
has notified us that these voting rights of 5.35% (628,462 voting rights)
are attributable to TAM UK Holdings Limited pursuant to sec. 22 para. 1
sent. 1 no. 6 in connection with sent. 2 WpHG.
The voting rights were attributed to TAM UK Holdings Limited inter alia
from Threadneedle Investment Funds ICVC, being a shareholder holding 3% or
more of the voting rights in STRATEC Biomedical AG.
3. Threadneedle Holdings Limited
Threadneedle Holdings Limited, London, UK, has notified us pursuant to sec.
21 para. 1 WpHG on 6 October 2014, that on 18 April 2013 the share of
voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.35% (628,462 voting rights).
Threadneedle Holdings Limited has notified us that these voting rights of
5.35% (628,462 voting rights) are attributable to Threadneedle Holdings
Limited pursuant to sec. 22 para. 1 sent. 1 no. 6 in connection with sent.
2 WpHG.
The voting rights were attributed to Threadneedle Holdings Limited inter
alia from Threadneedle Investment Funds ICVC, being a shareholder holding
3% or more of the voting rights in STRATEC Biomedical AG.
08.10.2014 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de
Language: English
Company: STRATEC Biomedical AG
Gewerbestr. 37
75217 Birkenfeld
Germany
Internet: www.stratec.com
End of Announcement DGAP News-Service
back